Amylyx Pharmaceuticals AMLX
NASDAQ AMLX
$29.41 +0.64 (+2.21%)
As of: Oct 21, 2026 · 2:52 PM EDT

Amylyx Pharmaceuticals (AMLX) Other financing activities (2021)

Updated

Analysis

Amylyx Pharmaceuticals (AMLX) Other financing activities (2021) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,136.71 Bn 1,105.29 Bn 19.71 Bn
2 Johnson & Johnson 617.55 Bn 536.07 Bn 17.26 Bn
3 AbbVie 501.02 Bn 474.13 Bn 12.70 Bn
4 Merck 368.18 Bn 322.56 Bn 12.21 Bn
5 Novartis Ag 297.89 Bn 261.88 Bn 11.24 Bn
6 Astrazeneca 261.33 Bn 235.02 Bn 12.86 Bn
7 Amgen 236.60 Bn 191.99 Bn 7.24 Bn
8 Gilead Sciences 190.55 Bn 164.75 Bn 6.22 Bn
9 Pfizer 169.77 Bn 116.42 Bn 10.94 Bn
10 Amylyx Pharmaceuticals 3.28 Bn 2.08 Bn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2021 -947,000.00
API Access

Amylyx Pharmaceuticals Other financing activities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-financing-activities&ticker=AMLX&period=max&api_key=YOUR_API_KEY